Short Interest in Mannatech, Incorporated (NASDAQ:MTEX) Grows By 62.2%

Mannatech, Incorporated (NASDAQ:MTEX) was the target of a large increase in short interest in May. As of May 15th, there was short interest totaling 41,501 shares, an increase of 62.2% from the April 30th total of 25,588 shares. Based on an average trading volume of 86,348 shares, the short-interest ratio is currently 0.5 days. Approximately 3.7% of the shares of the stock are short sold.

Analyst Ratings Changes

Separately, Weiss Ratings upgraded shares of Mannatech from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Tuesday, May 26th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock has an average rating of “Sell”.

Insider Buying and Selling at Mannatech

In other Mannatech news, Director Kevin Andrew Robbins bought 7,100 shares of the firm’s stock in a transaction dated Tuesday, May 19th. The shares were acquired at an average cost of $4.17 per share, for a total transaction of $29,607.00. Following the transaction, the director owned 33,333 shares in the company, valued at approximately $138,998.61. The trade was a 27.07% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. In the last quarter, insiders have bought 14,903 shares of company stock worth $62,155. 41.50% of the stock is currently owned by insiders.

Mannatech Price Performance

NASDAQ:MTEX traded down $0.02 on Thursday, reaching $5.75. The stock had a trading volume of 116 shares, compared to its average volume of 26,138. The company has a market capitalization of $11.10 million, a P/E ratio of -0.86 and a beta of 0.72. Mannatech has a 1-year low of $3.80 and a 1-year high of $12.45. The company has a quick ratio of 0.59, a current ratio of 1.09 and a debt-to-equity ratio of 0.48. The stock has a fifty day moving average price of $5.30 and a 200-day moving average price of $6.99.

Mannatech (NASDAQ:MTEX) last released its quarterly earnings results on Thursday, May 14th. The company reported $0.49 EPS for the quarter. The firm had revenue of $24.92 million for the quarter. Mannatech had a negative net margin of 11.97% and a negative return on equity of 2,383.34%.

About Mannatech

Mannatech, Inc is a global health and wellness company that develops and markets a range of dietary supplements and personal care products through a direct selling business model. The company’s core focus is on glyconutrients, specialized carbohydrates believed to support cellular communication, which form the basis of many of its flagship offerings. Operating under a network marketing structure, Mannatech empowers independent associates to promote and distribute its products in markets around the world.

The company’s product portfolio includes nutritional supplements aimed at immune support, digestive health, and healthy aging, as well as skincare items designed to promote hydration and skin vitality.